In this program we're going to talk about the goal of statin therapy: Is it LDL? Is it CRP? Also, we're going to talk about the JUPITER Trial. To discuss this topic are my really good experts here ...

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it ...

Chronic Pain May Quadruple Risk of Depression: Study FindsA new study published in Science Advances reveals that individuals suffering from ...

Presentation Title: Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass and Physical Function in Older Patients Receiving Semaglutide for Weight Loss Date: April 30, 2025 Start time: 12:30 ...

and reduce the inflammation biomarker high-sensitivity C-reactive protein in high-risk patients with high LDL cholesterol levels when statins are not working. Data from ODYSSEY OUTCOMES have also ...

A 2020 review and analysis of studies found berberine to "moderately but significantly" decrease weight, body mass index (BMI), waist circumference, and C-reactive protein (a marker of ...

Background: Statins that lower low-density lipoprotein (LDL ... After an average of four years, they found a statistically significant reduction in high-sensitivity CRP level by 0.34 mg/L in the ...